fda compounded glp 1 issued 25 warning letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of What Patients Need to Know
Description
The process is quick and virtually painless
Initial approval is usually 6 months
However, several considerations cast doubt on the endocrine mechanism of the GLP-1
NAION typically presents as sudden, painless vision loss in one eye and may also cause blurred vision, blind spots, reduced peripheral vision, or dimmed visual fields
Exendin-4 regulates endoplasmic reticulum stress to protect endothelial progenitor cells from high-glucose damage
These products are not FDA-approved drugs
